{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:40:54Z","timestamp":1788230454805,"version":"build-2803163510"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["FP-1607-24999"],"award-info":[{"award-number":["FP-1607-24999"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG-1606-08768"],"award-info":[{"award-number":["RG-1606-08768"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS082347"],"award-info":[{"award-number":["R01NS082347"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.540156","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T06:07:09Z","timestamp":1602137229000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":103,"title":["AQP4-IgG and MOG-IgG Related Optic Neuritis\u2014Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Angeliki G.","family":"Filippatou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loulwah","family":"Mukharesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Saidha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias S.","family":"Sotirchos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","article-title":"The investigation of acute optic neuritis: a review and proposed protocol","volume":"10","author":"Petzold","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation."},{"key":"B5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fneur.2018.00888","article-title":"Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis","volume":"9","author":"Borisow","year":"2018","journal-title":"Front Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin Oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am J Ophthalmol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519864928","article-title":"Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning","author":"Sotirchos","year":"2019","journal-title":"Mult Scler."},{"key":"B9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/WCO.0000000000000315","article-title":"Central nervous system neuroinflammatory disorders in Asian\/Pacific regions","volume":"29","author":"Kim","year":"2016","journal-title":"Curr Opin Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography","volume":"254","author":"Huang","year":"1991","journal-title":"Science."},{"key":"B12","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","article-title":"Optical coherence tomography in multiple sclerosis","volume":"32","author":"Britze","year":"2018","journal-title":"Eye."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/brain\/aws098","article-title":"Microcystic macular oedema in multiple sclerosis is associated with disease severity","volume":"135","author":"Gelfand","year":"2012","journal-title":"Brain."},{"key":"B17","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1474-4422(12)70213-2","article-title":"Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study","volume":"11","author":"Saidha","year":"2012","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1212\/WNL.0b013e31828c2f7a","article-title":"In vivo identification of morphologic retinal abnormalities in neuromyelitis optica","volume":"80","author":"Sotirchos","year":"2013","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","author":"Freeman","year":"1950","journal-title":"Ann Math Stat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e22947","DOI":"10.1371\/journal.pone.0022947","article-title":"The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials","volume":"6","author":"Warner","year":"2011","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00415-017-8583-z","article-title":"MOG antibody-related disorders: common features and uncommon presentations","volume":"264","author":"Cobo-Calvo","year":"2017","journal-title":"J Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1212\/NXI.0000000000000012","article-title":"Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton","volume":"1","author":"Dale","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/bjophthalmol-2019-314845","article-title":"MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis","volume":"104","author":"Ducloyer","year":"2020","journal-title":"Br J Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","article-title":"Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis","volume":"298","author":"Jarius","year":"2010","journal-title":"J Neurol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3341\/kjo.2018.0050","article-title":"Association of optic neuritis with neuromyelitis optica spectrum disorder and multiple sclerosis in Korea","volume":"33","author":"Kim","year":"2019","journal-title":"Korean J Ophthalmol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/08820538.2016.1208761","article-title":"Aquaporin 4 antibody in the Korean patient with new-onset optic neuritis","volume":"33","author":"Kim","year":"2018","journal-title":"Semin Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jns.2018.11.029","article-title":"The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis","volume":"396","author":"Liu","year":"2019","journal-title":"J Neurol Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1136\/jnnp-2019-320493","article-title":"Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up","volume":"90","author":"Petzold","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","article-title":"Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis","volume":"69","author":"Rostasy","year":"2012","journal-title":"Arch Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1177\/1352458517734070","article-title":"A population-based prospective study of optic neuritis","volume":"23","author":"Soelberg","year":"2017","journal-title":"Mult Scler."},{"key":"B33","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/bjophthalmol-2018-312399","article-title":"Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China","volume":"103","author":"Song","year":"2019","journal-title":"Br J Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2011.08.030","article-title":"Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage","volume":"312","author":"Storoni","year":"2012","journal-title":"J Neurol Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters","year":"2019","journal-title":"JAMA Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00415-017-8651-4","article-title":"Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China","volume":"265","author":"Zhao","year":"2018","journal-title":"J Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s00415-016-8155-7","article-title":"Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages","volume":"263","author":"Zhou","year":"2016","journal-title":"J Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/bjophthalmol-2017-310157","article-title":"Distinct clinical characteristics of atypical optic neuritis with seronegative aquaporin-4 antibody among Chinese patients","volume":"101","author":"Zhou","year":"2017","journal-title":"Br J Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/WNO.0000000000000668","article-title":"Aquaporin-4 serostatus and visual outcomes in clinically isolated acute optic neuritis","volume":"39","author":"Carnero Contentti","year":"2019","journal-title":"J Neuroophthalmol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamaophthalmol.2017.6757","article-title":"Prevalence of myelin oligodendrocyte glycoprotein and aquaporin-4-IgG in patients in the optic neuritis treatment trial","volume":"136","author":"Chen","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2018.03.003","article-title":"Clinical characteristics of pediatric optic neuritis with myelin oligodendrocyte glycoprotein seropositive: a cohort study","volume":"83","author":"Chen","year":"2018","journal-title":"Pediatr Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/ene.13315","article-title":"Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients","volume":"24","author":"Deschamps","year":"2017","journal-title":"Eur J Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/1352458513510223","article-title":"Relapsing optic neuritis: a multicentre study of 62 patients","volume":"20","author":"Benoilid","year":"2014","journal-title":"Mult Scler."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1212\/01.wnl.0000313375.20123.25","article-title":"Relapsing inflammatory optic neuritis: is it neuromyelitis optica?","volume":"70","author":"de Seze","year":"2008","journal-title":"Neurology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ophtha.2018.03.041","article-title":"Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis","volume":"125","author":"Jitprapaikulsan","year":"2018","journal-title":"Ophthalmology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00415-015-7844-y","article-title":"Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis","volume":"262","author":"Li","year":"2015","journal-title":"J Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","article-title":"Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor \u03b11 subunit in patients with isolated optic neuritis","volume":"72","author":"Martinez-Hernandez","year":"2015","journal-title":"JAMA Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jneuroim.2016.02.004","article-title":"Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica","volume":"293","author":"Akaishi","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","article-title":"MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study","volume":"87","author":"Akaishi","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2017.10.001","article-title":"Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica","volume":"313","author":"Akaishi","year":"2017","journal-title":"J Neuroimmunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/ene.13753","article-title":"Acute idiopathic optic neuritis: not always benign","volume":"25","author":"Deschamps","year":"2018","journal-title":"Eur J Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00415-016-8333-7","article-title":"Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration","volume":"264","author":"Havla","year":"2017","journal-title":"J Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/ana.24608","article-title":"Clinicopathological features in anterior visual pathway in neuromyelitis optica","volume":"79","author":"Hokari","year":"2016","journal-title":"Ann Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.18240\/ijo.2018.10.12","article-title":"Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis","volume":"11","author":"Mekhasingharak","year":"2018","journal-title":"Int J Ophthalmol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1136\/jnnp-2018-318382","article-title":"Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study","volume":"89","author":"Oertel","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12974-019-1521-5","article-title":"Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study","volume":"16","author":"Oertel","year":"2019","journal-title":"J Neuroinflammation."},{"key":"B57","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients","volume":"13","author":"Pache","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1136\/bjophthalmol-2016-309412","article-title":"Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography","volume":"101","author":"Peng","year":"2017","journal-title":"Br J Ophthalmol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0170847","DOI":"10.1371\/journal.pone.0170847","article-title":"Retinal nerve fiber layer may be better preserved in MOG-IgG versus AQP4-IgG optic neuritis: a cohort study","volume":"12","author":"Stiebel-Kalish","year":"2017","journal-title":"PLoS ONE."},{"key":"B60","doi-asserted-by":"publisher","first-page":"832784","DOI":"10.1155\/2015\/832784","article-title":"Evaluation of retinal nerve fiber layer and ganglion cell complex in patients with optic neuritis or neuromyelitis optica spectrum disorders using optical coherence tomography in a Chinese cohort","volume":"2015","author":"Tian","year":"2015","journal-title":"J Ophthalmol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jocn.2018.06.052","article-title":"The application of RNFL thickness detection in early differential diagnosis among various types of idiopathic optic neuritis","volume":"55","author":"Zhang","year":"2018","journal-title":"J Clin Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12886-018-0902-3","article-title":"A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis","volume":"18","author":"Zhao","year":"2018","journal-title":"BMC Ophthalmol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/dmcn.13757","article-title":"Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome","volume":"60","author":"Eyre","year":"2018","journal-title":"Dev Med Child Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.18240\/ijo.2018.01.16","article-title":"Retinal ganglion cell-inner plexiform and nerve fiber layers in neuromyelitis optica","volume":"11","author":"Hu","year":"2018","journal-title":"Int J Ophthalmol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10072-014-1635-6","article-title":"First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis","volume":"35","author":"Lim","year":"2014","journal-title":"Neurol Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/1756285616655264","article-title":"Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders","volume":"9","author":"Martinez-Lapiscina","year":"2016","journal-title":"Ther Adv Neurol Disord."},{"key":"B67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.msard.2018.11.026","article-title":"Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients","volume":"28","author":"Narayan","year":"2019","journal-title":"Mult Scler Relat Disord."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1352458515578888","article-title":"A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"21","author":"Outteryck","year":"2015","journal-title":"Mult Scler."},{"key":"B69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ophtha.2018.06.022","article-title":"Differing structural and functional patterns of optic nerve damage in multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"126","author":"Shen","year":"2019","journal-title":"Ophthalmology."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1177\/1352458513519838","article-title":"Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders","volume":"20","author":"von Glehn","year":"2014","journal-title":"Mult Scler."},{"key":"B71","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ophtha.2019.01.016","article-title":"Evidence of m\u00fcller glial dysfunction in patients with aquaporin-4 immunoglobulin g-positive neuromyelitis optica spectrum disorder","volume":"126","author":"You","year":"2019","journal-title":"Ophthalmology."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2055217318791196","DOI":"10.1177\/2055217318791196","article-title":"Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis","volume":"4","author":"Srikajon","year":"2018","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2055217318787829","DOI":"10.1177\/2055217318787829","article-title":"MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response","volume":"4","author":"Pandit","year":"2018","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"B74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jneuroim.2016.09.007","article-title":"Different etiologies and prognoses of optic neuritis in demyelinating diseases","volume":"299","author":"Akaishi","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"104319","DOI":"10.1016\/j.neuint.2018.10.016","article-title":"Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein","volume":"130","author":"Akaishi","year":"2019","journal-title":"Neurochem Int."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Epidemiologic and clinical characteristics of optic neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Ophthalmology."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3389\/fneur.2019.01076","article-title":"Retinal Degeneration after first-ever optic neuritis helps differentiate multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"10","author":"Kim","year":"2019","journal-title":"Front Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00415-015-7983-1","article-title":"Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up","volume":"263","author":"Piccolo","year":"2016","journal-title":"J Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Scler."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1212\/NXI.0000000000000225","article-title":"Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus","volume":"3","author":"Sep\u00falveda","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B83","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3988\/jcn.2018.14.3.351","article-title":"Recurrent optic neuritis as the initial symptom in demyelinating diseases","volume":"14","author":"Falc\u00e3o-Gon\u00e7alves","year":"2018","journal-title":"J Clin Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2147\/OPTH.S43894","article-title":"Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis","volume":"2013","author":"Merle","year":"2013","journal-title":"Clin Ophthalmol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3892\/etm.2018.6273","article-title":"Diagnostic implications of MOG\/AQP4 antibodies in recurrent optic neuritis","volume":"16","author":"Peng","year":"2018","journal-title":"Exp Ther Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1874364101812010247","article-title":"Clinical characteristics, treatment outcomes and predictive factors in optic neuritis","volume":"12","author":"Hansapinyo","year":"2018","journal-title":"Open Ophthalmol J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/WNO.0b013e3181f8a693","article-title":"Neuromyelitis optica antibodies in patients with severe optic neuritis in China","volume":"31","author":"Lai","year":"2011","journal-title":"J Neuroophthalmol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e007766","DOI":"10.1136\/bmjopen-2015-007766","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis","volume":"5","author":"Nakajima","year":"2015","journal-title":"BMJ Open."},{"key":"B89","doi-asserted-by":"publisher","first-page":"568254","DOI":"10.1155\/2014\/568254","article-title":"The frequency of anti-aquaporin-4 Ig g antibody in neuromyelitis optica and its spectrum disorders at a single tertiary referral center in malaysia","volume":"2014","author":"Viswanathan","year":"2014","journal-title":"Mult Scler Int."},{"key":"B90","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2055217317730098","DOI":"10.1177\/2055217317730098","article-title":"Epidemiology of neuromyelitis optica in Latin America","volume":"3","author":"Alvarenga","year":"2017","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"B92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jneuroim.2010.11.004","article-title":"HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese","volume":"233","author":"Wang","year":"2011","journal-title":"J Neuroimmunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/1352458508102085","article-title":"Is neuromyelitis optica associated with human leukocyte antigen?","volume":"15","author":"Z\u00e9phir","year":"2009","journal-title":"Mult Scler."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1136\/jnnp-2020-323158","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK","volume":"91","author":"O'Connell","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1212\/NXI.0000000000000468","article-title":"Mortality in neuromyelitis optica is strongly associated with African ancestry","volume":"5","author":"Mealy","year":"2018","journal-title":"Neurology."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e66151","DOI":"10.1371\/journal.pone.0066151","article-title":"Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis","volume":"8","author":"Schneider","year":"2013","journal-title":"PLoS ONE."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1136\/jnnp.2008.166207","article-title":"Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis","volume":"80","author":"Green","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain."},{"key":"B101","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1212\/NXI.0000000000000334","article-title":"Microstructural visual system changes in AQP4-antibody-seropositive NMOSD","volume":"4","author":"Oertel","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e805","DOI":"10.1212\/NXI.0000000000000805","article-title":"Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders","volume":"7","author":"Motamedi","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1212\/NXI.0000000000000347","article-title":"Foveal thinning in neuromyelitis optica: a sign of retinal astrocytopathy?","volume":"4","author":"Yamamura","year":"2017","journal-title":"Neurology Neuroimmunol Neuroinflamm."},{"key":"B105","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12974-016-0746-9","article-title":"Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G","volume":"13","author":"Felix","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1002\/jnr.22437","article-title":"Deletion of aquaporin-4 renders retinal glial cells more susceptible to osmotic stress","volume":"88","author":"Pannicke","year":"2010","journal-title":"J Neurosci Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0042-6989(83)90063-9","article-title":"Nerve fiber layer of the primate retina: thickness and glial content","volume":"23","author":"Ogden","year":"1983","journal-title":"Vision Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-vision-091517-034425","article-title":"Microglia in the retina: roles in development, maturity, and disease","volume":"4","author":"Silverman","year":"2018","journal-title":"Annu Rev Vis Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ncl.2016.08.012","article-title":"Optical coherence tomography in neuro-ophthalmology","volume":"35","author":"Costello","year":"2017","journal-title":"Neurol Clin."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","article-title":"Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica","volume":"87","author":"Waters","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jamaneurol.2014.1581","article-title":"Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis","volume":"71","author":"Pittock","year":"2014","journal-title":"JAMA Neurol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.540156\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T06:07:16Z","timestamp":1602137236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.540156\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":112,"alternative-id":["10.3389\/fneur.2020.540156"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.540156","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"article-number":"540156"}}